Get started
Author

Josée Hue-Perron

Observed names: Josee Hue-Perron, Josée Hue Perron
ORCID: 0009-0004-2289-2545
Observed ORCID: 0009-0004-2289-2545
OpenAlex ID: A5093394198
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo
2025 · Vincent Gerusz, Pierre Regenass, et al. · Nature Communications · 8
PDF
HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth
2026 · Jacques Huck, Caroline Joannesse, et al. · Journal of Medicinal Chemistry · 3
Debio 1562M, a Next Generation Antibody Drug Conjugate (ADC) Targeting CD37 for AML and MDS Treatment
2023 · Lisa Ivanschitz, Josée Hue-Perron, et al. · Blood · 3
Discovery and Characterization of GLPG3808, a PAPD5/7 Inhibitor for Suppression of Hepatitis B Viral Infections
2026 · Oscar Mammoliti, Adeline Palisse, et al. · Journal of Medicinal Chemistry · 2
Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS
2026 · Léo Marx, Josée Hue-Perron, et al. · Cell Reports Medicine · 1
Abstract 1160: Debio 1562M, a 2ndgeneration ADC targeting CD37, shows high potency against AML and MDS and safe toxicological profile for future clinical development
2025 · Lisa Ivanschitz, Josée Hue-Perron, et al. · Cancer Research
Works count: 6
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type